ArticleFrontiers in pharmacology2022

β-Glucan Combined With PD-1/PD-L1 Checkpoint Blockade for Immunotherapy in Patients With Advanced Cancer.

Mengjie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.